6e5p
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Backbone model based on cryo-EM map at 8.5 A of domain-swapped, glycan-reactive, neutralizing antibody 2G12 bound to HIV-1 Env BG505 DS-SOSIP, which was also bound to CD4-binding site antibody VRC03== | ==Backbone model based on cryo-EM map at 8.5 A of domain-swapped, glycan-reactive, neutralizing antibody 2G12 bound to HIV-1 Env BG505 DS-SOSIP, which was also bound to CD4-binding site antibody VRC03== | ||
| - | < | + | <SX load='6e5p' size='340' side='right' viewer='molstar' caption='[[6e5p]], [[Resolution|resolution]] 8.80Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[6e5p]] is a 24 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6E5P OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6E5P FirstGlance]. <br> | <table><tr><td colspan='2'>[[6e5p]] is a 24 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6E5P OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6E5P FirstGlance]. <br> | ||
| Line 18: | Line 18: | ||
</div> | </div> | ||
<div class="pdbe-citations 6e5p" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 6e5p" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Gp120 3D structures|Gp120 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
| - | </ | + | </SX> |
| + | [[Category: Large Structures]] | ||
[[Category: Acharya, P]] | [[Category: Acharya, P]] | ||
[[Category: Kwong, P D]] | [[Category: Kwong, P D]] | ||
Revision as of 21:01, 6 March 2020
Backbone model based on cryo-EM map at 8.5 A of domain-swapped, glycan-reactive, neutralizing antibody 2G12 bound to HIV-1 Env BG505 DS-SOSIP, which was also bound to CD4-binding site antibody VRC03
| |||||||||
